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Rhesus D incompatibility increases risk for schizophrenia, with some evidence that risk is limited to male offspring. The
purpose of this study is to determine whether risk for schizophrenia due to Rhesus D incompatibility differs by offspring sex
using a nuclear family-based candidate gene approach and a meta-analysis approach. The genetic study is based on a sample of
277 nuclear families with RHD genotype data on at least one parent and at least one child diagnosed with schizophrenia or
related disorder. Meta-analysis inclusion criteria were (1) well-defined sample of schizophrenia patients with majority born
before 1970, (2) Rhesus D incompatibility phenotype or genotype data available on mother and offspring, and by offspring sex.
Two of ten studies, plus the current genetic study sample, fulfilled these criteria, for a total of 358 affected males and 226
affected females. The genetic study found that schizophrenia risk for incompatible males was significantly greater than for
compatible offspring (p=0.03), while risk for incompatible and compatible females was not significantly different (p= .32).
Relative risks for incompatible males and females were not significantly different from each other. Meta-analysis using a larger
number of affected males and females supports their difference. Taken together, these results provide further support that risk of
schizophrenia due to Rhesus D incompatibility is limited to incompatible males, although a weak female incompatibility effect⁎ Corresponding author. UCLA Semel Institute, 760 Westwood Plaza, Rm 47-422, Los Angeles, CA 90095, USA. Tel.: +1 310 794 4796; fax: +1
310 206 4446.
E-mail address: cpalmer@mednet.ucla.edu (C.G.S. Palmer).
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136 C.G.S. Palmer et al. / Schizophrenia Research 104 (2008) 135–145cannot be excluded. Sex differences during fetal neurodevelopment should be investigated to fully elucidate the etiology of
schizophrenia.
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Schizophrenia is a debilitating disorder with amixture
of characteristic signs and symptoms, both positive and
negative, affecting ∼1% of the population (American
Psychiatric Association, 1994). The positive symptoms
include distortions in thought content (delusions),
perception (hallucinations), language and thought pro-
cess (disorganized speech), and self-monitoring of
behavior (grossly disorganized or catatonic behavior).
Negative symptoms include restrictions in the range and
intensity of emotional expression (affective flattening),
in the fluency and productivity of thought and speech
(alogia), and in the initiation of goal-directed behavior
(avolition) (American Psychiatric Association, 1994).
Although the etiology of schizophrenia is unknown, it is
likely a complex disorder involving genetic and
environmental factors (Mueser and McGurk, 2004).
Sex differences in schizophrenia have been noted
since Kraepelin found that dementia praecox occurred
primarily in young men (Kraepelin, 1919/1971), and
more recent investigations have revealed a number of sex
differences in the characteristics of schizophrenia.
Several recent studies have reported that males have a
higher risk for developing schizophrenia compared to
females. For example, Aleman et al. (2003) and Thorup
et al. (2007) both find that the incident rate is higher in
males than in females in ∼1.4:1 ratio. Compared to
females, males experience an earlier age at onset of
schizophrenia (Castle and Murray, 1991; Mueser and
McGurk, 2004; Thorup et al., 2007), have poorer
premorbid social and intellectual functioning, poorer
course and medication response, and greater structural
brain abnormalities (Salem and Kring, 1998). Sympto-
matology also differs by sex, with males exhibiting more
negative symptoms and females exhibiting more affec-
tive symptoms (Leung and Chue, 2000). Identification of
sex-specific differences in schizophrenia is important
because they may yield further clues about the etiology
of this disorder, and this is the focus of the current paper.
Although the explanation for sex-specific differences
is not yet known, some researchers suggest that male–
female differences in schizophrenia may be explainedthrough a neurodevelopmental perspective, where more
males than females are likely to experience a form of the
disease due to a neurodevelopmental anomaly resulting
from early environmental influences (Castle and
Murray, 1991). The neurodevelopmental hypothesis of
schizophrenia is supported by numerous accounts of an
association between obstetric complications (a form of
early environmental influence) and risk of developing
schizophrenia (Byrne et al., 2007; Cannon et al., 2000;
Clarke et al., 2006; Geddes and Lawrie, 1995), which
fall into three general categories: complications of
pregnancy (bleeding, diabetes, rhesus incompatibility,
preeclampsia), abnormal fetal growth (low birthweight,
congenital malformations, reduced head circumference)
and development, and complications of delivery (uterine
atony, asphyxia, emergency Cesarean section) (Cannon
et al., 2002). The role of the prenatal environment in
schizophrenia is also supported by a recent meta-
analysis of 12 twin studies which found that common or
shared environment (which would most likely occur
very early in life, i.e., prenatally) had a nontrivial
contribution to the heritability of schizophrenia (∼11%)
(Sullivan et al., 2003).
Although the prenatal environment offers one plau-
sible source for male–female differences in schizophre-
nia, there have been few detailed sex-specific studies and
the results of such studies as yet are inconclusive. Some
studies have documented an increased frequency of
obstetric complications in pregnancies of males with
schizophrenia (Byrne et al., 2000; Dalman et al., 1999;
Hultman et al., 1999; O'Callaghan et al., 1992; Preti et al.,
2000), others have documented an increased frequency of
obstetric complications in pregnancies of females with
schizophrenia (Verdoux and Bourgeois, 1993), and still
other studies have concluded that there is no difference in
rates of obstetric complications by sex of affected
individuals (Byrne et al., 2007; Geddes et al., 1999;
Verdoux et al., 1997). However, when we draw our
attention to specific obstetric complications, such as
RhesusD incompatibility, there is evidence to suggest that
there may be sex-specific differences related to risk for
schizophrenia (Byrne et al., 2000; Hollister et al., 1996;
Insel et al., 2005) and that is the focus of this paper.
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of red blood cells (Guyton, 1981). The RHD locus
[MIM 111680] (Online Mendelian Inheritance in Man)
codes for the Rhesus D factor, and individuals are
classified as Rhesus D positive or negative if the Rhesus
D factor is present or absent on their red blood cells,
respectively. Rhesus D status can be determined either
genotypically or serologically (Wagner and Flegel,
2000; Westhoff, 2007). Rhesus D incompatibility is
defined as a Rhesus D negative pregnant female with a
Rhesus D positive fetus. Rhesus D incompatibility can
result in maternal isoimmunization against fetal red
blood cells and their subsequent hemolysis during
pregnancy and in the neonatal period (Guyton, 1981).
This process can lead to fetal and neonatal hypoxia and
hyperbilirubinemia (Guyton, 1981), conditions that
have been associated with schizophrenia (Amit and
Brenner, 1993; Cannon, 1997; Cannon et al., 2000;
Dalman et al., 2001; Hansen, 2000, 2001; Moises et al.,
2002). The outcomes of Rhesus D incompatibility are
variable (Plevyak and Carr, 2001) and Rhesus D
hemolytic disease of the newborn (HDN) is a term
used to describe the clinically measurable adverse
outcomes of Rhesus D incompatibility in the neonatal
period, e.g., anemia, hyperbilirubinemia, which in their
most severe manifestation can lead to hydrops fetalis,
kernicterus, and death (Bowman, 1998; Plevyak and
Carr, 2001). The maternal immune response depends on
previous exposure to fetal Rhesus D positive antigens
during pregnancy or delivery, and the first incompatible
pregnancy generally is not at risk for HDN (Guyton,
1981). However, among Rhesus negative women who
have been isoimmunized, all subsequent incompatible
pregnancies are at risk for HDN. Prophylaxis against
maternal isoimmunization became available in North
America in 1968 (Bowman, 1998) and in Finland in
1969 (Eklund and Nevanlinna, 1986), and has since
significantly reduced morbidity and mortality of Rhesus
D incompatibility worldwide.
There have been eight studies (Byrne et al., 2000;
Hollister and Kohler, 2001; Hollister et al., 1996; Insel
et al., 2005; Kendell et al., 2000; Kraft et al., 2004; Palmer
et al., 2002; Sacker et al., 1995) and 2 meta-analyses
(Cannon et al., 2002; Geddes et al., 1999) to directly or
indirectly examineRhesusD incompatibility as a risk factor
for schizophrenia (briefly summarized in Table 1). The
indirect studies tend to represent the earlier studies of
Rhesus D incompatibility and schizophrenia, and are based
on maternal recall or information from labor and birth
records ascertained retrospectively or prospectively. Direct
studies of Rhesus D incompatibility and schizophrenia are
more recent and are based on serologic or genotype datafrom medical records or typed specifically for the study.
Although the studies vary in the use of direct and indirect
measures of Rhesus D incompatibility, collectively there is
compelling evidence that RhesusD incompatibility is a risk
factor for schizophrenia (see Table 1). Moreover, in those
studies that examined male–female differences in risk
(Byrne et al., 2000; Hollister et al., 1996; Insel et al., 2005;
Kendell et al., 2000; Sacker et al., 1995), there is evidence
from several to suggest that the risk may be limited to male
offspring, with relative risk ranging from 2.02–3.32.
However, due to small subgroup sample sizes, particularly
for affected female offspring, and variability in the use of
direct and indirect measures of Rhesus D incompatibility,
these sex-specific results remain inconclusive.
In this paper, we investigate if the effect of Rhesus D
incompatibility on schizophrenia is limited to male
offspring using a direct measure of Rhesus D incompat-
ibility and two methodological approaches. The first
methodological approach uses a direct measure of
Rhesus D incompatibility in a candidate gene study of
277 nuclear families—the 181 nuclear families with at
least one child diagnosed with schizophrenia or a related
disorder previously analyzed (Kraft et al., 2004) plus an
additional 96 nuclear families. The second approach
uses meta-analysis to combine the results of the current
analysis with sex-specific information on Rhesus D
incompatibility available in two earlier studies that
classified Rhesus D incompatibility using a direct
measure (Hollister et al., 1996; Insel et al., 2005).
2. Materials and methods
2.1. Subjects
Subjects were ascertained from a larger well-described
and characterized Finnish sample of schizophrenia
patients and their families (Ekelund et al., 2001; Ekelund
et al., 2000; Hovatta et al., 1999; Paunio et al., 2001).
Briefly, probands, born between 1940 and 1969, were
initially identified through nationwide population and
health registries, and first-degree relatives were contacted
with permission from the proband. Informed consent was
obtained from all subjects. DSM-IV (American Psychia-
tric Association, 1994) best estimate psychiatric diag-
noses on probands and their relatives were made by two
independent psychiatrists or psychiatric residents from
information recorded in inpatient and outpatient medical
records. The research was approved by the Ministry of
Social Affairs and Health (Finland) and the institutional
review board at the University of California, Los Angeles
(USA). Individuals were classified as affected if theywere
diagnosed with schizophrenia, schizoaffective psychosis
Table 1
Description of studies examining Rhesus D incompatibility as a schizophrenia risk factor
Study Birth years
(cases)
Measure of Rhesus D
incompatibility
Rhesus D
incompatibility effect
Sex-specific Rhesus D
incompatibility effect
Hollister et al. (1996) 1959–1961 Rhesus D serotypes from
medical records on mother
and child
RR=1.99 (p=0.12) All males:
RR=2.78 (p=0.03)
2nd or later born males:
RR=3.32 (p=0.05)
All Females:
RR=0.53 (p=1.0)
2nd or later born females: not
examined due to small sample
size
Insel et al. (2005) 1959–1967 Rhesus D serotypes from
blood samples collected from
mother and child at delivery
aRRadj=1.80 (95% CI 0.71–4.58) 2nd or later born males:
RR=2.02 (95% CI 0.71–5.79)
RRadj=2.37 (95% CI 0.82–6.86)
2nd or later born females:
RR=0.90 (95% CI 0.12–6.74)
RRadj=0.93 (95% CI 0.12–7.01)
Palmer et al. (2002) 1940–1969 Rhesus D genotypes from
blood samples collected from
mother and child
RR=2.26 (p=0.027) Not examined
Kraft et al. (2004) b 1940–1969 Rhesus D genotypes from
blood samples collected from
mother and child
2nd or later born offspring
RR=1.7 (p=0.014)
Not examined
Sacker et al. (1995) 1958 Mother noted as Rhesus
negative in medical record
OR=1.79 (pb0.05) Not examined
Kendell et al. (2000) 1971–1974 Presence of Rhesus D
antibodies noted in medical
record
OR=6.0 (p=0.10) Reported as non-significant
Byrne et al. (2000) Before 1972 c Not explicit Not reported Males: 1:255 cases to 0:256
controls (sample too small to
compute stable estimates)
Females: 2:173 cases to 2:173
controls
Hollister and Kohler (2001) 1955–1967 Evidence of hemolytic
disease of the newborn in
medical record
OR=2.0 (pb0.05) Not examined
Geddes and Lawrie (1995)
(meta-analysis)
Before 1976 d Evidence of hemolytic
disease of the newborn in
medical record or by
maternal recall
OR=1.4 (p=0.49) Reported as non-significant
Cannon et al. (2002)
(meta-analysis of
Sacker et al., 1995;
Kendell et al., 2000;
Byrne et al., 2000)
∼1958–1974 Mother noted as Rhesus
negative in medical record;
Presence of Rhesus D
antibodies noted in medical
record; or not explicit
OR=2.0 (pb0.05) Not examined
a RRadj are adjusted for maternal age and ethnicity.
b Contains same nuclear families analyzed in Palmer et al., 2002, but expanded to include all genotyped affected and unaffected offspring.
c Cases most likely born before 1972 because they were diagnosed with schizophrenia between 1972 and 1992.
d Meta-analysis of studies published between 1990 and 1996, so cases likely born before 1976.
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personality, schizoid personality, or schizotypy). Inde-
pendent nuclear families with at least one genotyped
parent and at least one genotyped affected child were used
in the analysis.
The study sample is comprised of 277 nuclear families
with the number of children ranging from1 to 7 per family.Of the 677 children, 505 were classified as affected (303
affectedmales, 202 affected females). Genotype data were
available on both parents in 132 families, while they were
available only for the mother in 107 families, and only for
the father in 38 families. 58 affected offspring were
determined to be either unambiguously Rhesus D
incompatible with their mothers (24 males, 14 females)
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and offspring, or potentially incompatible with their
mothers (15 males, 5 females) in the case of heterozygous
offspringwithRhesusDpositive fathers,missingmaternal
genotypes, and sibling genotypes that are consistent with a
Rhesus D negative mother. In 21 independent families the
unambiguously or potentially incompatible affected off-
spring were male, in 6 families the incompatible offspring
were female, and in 10 families both male and female
incompatible offspring were present. Birth years for the
offspring ranged from 1923–1976, with only 12 offspring
born in or after 1970, the era when prophylaxis against
maternal isoimmunization became widely used in Finland
(Eklund and Nevanlinna, 1986). However, none of these
12 individuals resulted from incompatible pregnancies
and so it is unlikely that the prophylaxis was used or was
even necessary.
2.2. Genotyping methods
A standard procedure was used to extract DNA from
EDTA blood (Blin and Stafford, 1976) and a PCR-
RFLP method was used to identify all three RHD
genotypes (D/D, D/d, and d/d) (Wagner and Flegel,
2000). PCR was performed using primers rez7 (5′-
CCTGTCCCCATGATTCAGTTACC-3') and rnb1 (5'-
CCTTTTTTTGTTTGTTTTTGGCGGTGC-3′) and the
expand high fidelity PCR system (DyNAzyme™ EXT
DNA Polymerase). Annealing was at 65 °C and
extension was for 3 min at 72 °C. PCR products were
digested with PstI for 3 h at 37 °C, and fragments were
visualized using a 1.5% agarose gel. Genotyping was
performed blind to diagnostic status and sex. Genotype
data were checked for genotyping errors using Mendel
6.0 (Lange et al., 2001) resulting in the exclusion of 5
families with genotyping error probabilities ≥0.50.
There was no evidence for violation of Hardy–Weinberg
equilibrium among the founders (p=0.6). Among the
409 genotyped parents, 52 were dd, 189 were Dd, and
168 were DD; the frequency of the D and d alleles were
64.2% and 35.8%, respectively. These data are compar-
able to the frequency of Rhesus D negative (dd)
individuals in Finland (∼12%) (Finnish Red Cross),
and the frequency of the d allele in the Finnish
population (∼34%) (Harvey et al., 1983).
2.3. Statistical analyses
For the purposes of these analyses, the RHD gene is
treated as diallelic, with D denoting all polymorphisms
that lead to protein expression and d alleles denoting all
polymorphisms that do not. An individual who inheritstwo d alleles (dd) is Rhesus D negative while those who
inherit at least one D allele (Dd or DD) are Rhesus D
positive. Rhesus D incompatibility occurs when the
mother is dd and the child is Dd. To test for association of
Rhesus D incompatibility and schizophrenia, we used a
conditional log-linearmodel (Kraft et al., 2004) which is a
multi-sibling extension of the maternal-fetal genotype
incompatibility (MFG) test (Sinsheimer et al., 2003).
The parental and offspring genotype data are
modeled as conditional on the offspring phenotypes.
Each family is independent so Eq. (1) denotes the total
likelihood from N families
j
N
i¼1
Pr G ið Þc ;G
ið Þ
p jD ið Þ
 
ð1Þ
The index i=1,…, N, denotes family,Gc
(i) = (Gcl
(i),…
Gcni
(i) ) denote the genotypes of the ni offspring, in which
Ki are affected;Gp
(i) = (Gm
(i),Gf
(i)) denote parental geno-
types, in which Gm
(i) and Gf
(i) are maternal and paternal
genotypes, respectively and D(i) = (D1
(i),…Dni
(i)) denotes
the affection status for each offspring. Unaffected
offspring are treated as phenotype unknown (missing)
since the prevalence of schizophrenia is relatively low
(Hsieh et al., 2006a). In assuming that affected siblings'
phenotypes are independent given their parental geno-
types, we can express likelihood (Eq. (1)) as a function of
the offspring's penetrance, Mendelian transmission
probabilities, and population mating type frequencies
(Eq. (2)) using Bayes theorem,
j
i
Pr G ið Þc ;G
ið Þ
p jD ið Þ
 
¼ j
i
Pr G ið Þc jG ið Þp
 
Pr G ið Þp jMTi
 
wMTijk¼1 Pr D
ið Þ
ck jG ið Þck ;G ið Þm
 
Pr D ið Þ
  ;
ð2Þ
where MTi indexes the parental mating type and the
nuisance parameters ψMTi are population mating-type
frequencies. Our penetrance function Pr(Dck
(i)|Gck
(i),Gm
(i)), the
probability of the offspring phenotype given the offspring
genotype and maternal genotype, differs from the
standard genetic penetrance function Pr(Dck
(i)|Gck
(i)), the
probability of the offspring phenotype given the offspring
genotype only. As in previous analyses of multiple
affected siblings (Hsieh et al., 2007; Hsieh et al., 2006a;
Kraft et al., 2004), we model the penetrance as a function
of the relative risks of disease for offspring depending on
their risk category. Based on the results of previous studies
(Kraft et al., 2004; Palmer et al., 2002), we exclude child
allelic effects. Incompatibility is defined as the combina-
tion of maternal genotype=dd (Rhesus D negative) and
affected offspring genotype=Dd (Rhesus D positive); all
140 C.G.S. Palmer et al. / Schizophrenia Research 104 (2008) 135–145remaining maternal-offspring genotype combinations are
treated as non-risk. In our most general hypothesis, we
include two variables, Minc, which equals 1 when a male
offspring is incompatiblewith hismother and 0when he is
compatible, and Finc, which equals 1 when a female
offspring is incompatible with mother and 0 when she is
compatible. The penetrance function is then
Pr DckjGck;Gmð Þ ¼ blI Minc½ male lI Finc½ f emale: ð3Þ
I[.] is the indicator function and the parameter β
denotes the population baseline disease incidence rate,
which will cancel from (Eq. (2)). The parameter µmale is
the risk of schizophrenia for incompatible males and the
parameter µfemale is the risk for incompatible females,
both relative to any compatible offspring. Note that
these relative risks are defined on the non-negative real
line, and have null values of 1. Different models are
generated for hypothesis testing by applying specific
constraints to these parameters. As examples, placing
µfemale=1 assumes that the incompatibility effect is
limited to males, while setting µmale=µfemale assumes
that the incompatibility effect does not depend on
offspring sex. Both of these models have one degree of
freedom less than our most general model. The
numerical maximization of the log-likelihood is better
conditioned when we use the natural logarithm of the
relative risks as parameters so we actually estimate ln
(µmale) and ln(µfemale); however we present the non-
logged values throughout this paper.
As previously (Kraft et al., 2004; Palmer et al., 2002;
Sinsheimer et al., 2003), the model is constructed without
assumptions of Hardy–Weinberg equilibrium or random
mating. Instead we make a more mild assumption of
mating symmetry in the general population from which
these families were ascertained. Under this assumption,
there are six possible mating types. Data from families
with incomplete parental genotypes can be included in
(Eq. (2)) by assuming the genotypes are missing at
random and summing over all possible parental genotypes
(Hsieh et al., 2006b; Kraft et al., 2004). TheMFG test also
assumes that the probability of an affected individual
surviving to clinical detection is independent of the
maternal, paternal, and affected child's genotypes.
However, the MFG test is insensitive to small violations
of this assumption (Hsieh et al., 2006a), which is the case
in these analyses because most children survive the
sequelae of Rhesus D incompatibility even without
prophylaxis (Plevyak and Carr, 2001).
The constrained log-likelihoods were maximized and
maximum likelihood estimates of the parameters obtained
using an application of the non-linear optimizationprogram Search (Hsieh et al., 2006b; Lange, 1991).
Likelihood ratio test (LRT) statistics and Akaike's
information criterion (AIC) were used to compare
different models, where smaller AIC values indicate a
better fitting model (Burnham and Anderson, 1998).
Where appropriate one-sided p-values are reported
because prior evidence suggests that the Rhesus D
incompatibility effect is deleterious (M. Cannon et al.,
2002;Hollister et al., 1996; Insel et al., 2005; Palmer et al.,
2002). The significance level for the LRTs is set at 0.05.
We also performed a meta-analysis using a fixed
effects model (Fleiss, 1993) to estimate the Rhesus D
incompatibility effect for males and females. For the
meta-analysis, we used data generated from our study
and data published in studies that fulfilled the following
set of criteria: (1) well-defined sample of schizophrenia
patients with the majority born before 1970, (2) Rhesus
D incompatibility phenotype or genotype data available
on mother and offspring, and by offspring sex.
The search strategies of a computerized MEDLINE
search of English only studies published before
November 2007 using search terms Rhesus D incompat-
ibility, Rh incompatibility, or hemolytic disease of the
newborn coupled with schizophrenia, cross-referencing
of studies, and contacting researchers identified the 10
studies listed in Table 1. Two studies fulfilled our criteria
for inclusion in the meta-analysis (Hollister et al., 1996;
Insel et al., 2005). The remaining eight studies were not
included either because their samples are a subset of the
Finnish schizophrenia sample analyzed in the candidate
gene study reported here (Kraft et al., 2004; Palmer et al.,
2002) or because they used inferred indicators of
maternal and offspring Rhesus D phenotypes which
were either too broad for classifying Rhesus D
incompatibility (Sacker et al., 1995) or too narrow for
classifying Rhesus D incompatibility (Byrne et al., 2000;
Cannon et al., 2002; Geddes et al., 1999; Hollister and
Kohler, 2001; Kendell et al., 2000).
For the meta-analysis, a male and female relative risk,
µmale and µfemale respectively, was computed separately
for the three studies. These relative risks were computed
from the raw data available from the Finnish schizo-
phrenia study sample and from the published data in
Hollister et al. (1996) and Insel et al. (2005). To generate
the largest possible sample size for analysis, we used data
from all incompatible and compatible offspring in the
Finnish schizophrenia study sample (303 affected males,
202 affected females) and the Hollister et al. sample (21
affected males, 5 affected females), and we used data
from 2nd or later born incompatible and compatible
offspring in the Insel et al. sample (34 affected males, 19
affected females) as a result of their definition of Rhesus
Table 3
Parental genotype combinations under model where Rhesus D
incompatibility effect is limited to male offspring
Father Mother
dd Dd DD
dd 11.54 12.06 7.85
Dd 15.17 71.27 45.33
DD 12.07 40.16 61.55
141C.G.S. Palmer et al. / Schizophrenia Research 104 (2008) 135–145D incompatibility. To make the analyses as comparable
as possible between studies, we used relative risks that
were unadjusted for censoring or covariates. This
decision led to relative risks for the Insel et al. (2005)
data that are slightly smaller than their published values.
A homogeneity statistic, Q, was calculated to determine
if there is evidence for a study-by-effect size interaction.
This value follows a chi-square distribution with (#
studies—1) degrees of freedom (Fleiss, 1993). Statistical
evidence for heterogeneity would suggest that the studies
should not be combined in a meta-analysis framework.
3. Results
3.1. Candidate gene study
First, we performed a series of analyses in order to test
the hypothesis that the effect of Rhesus D incompatibility
on schizophrenia is limited to males in our sample. Using
the MFG test we estimated the parameters of a fully
unconstrained model, i.e., one that estimates the male and
female incompatibility effects separately (Table 2, Model
1). Inspection of Model 1 reveals that the estimate for the
male incompatibility effect [µmale=1.44, 90% CI: 1.05–
1.98] is higher than the female incompatibility effect
[µfemale=1.12, 90% CI: 0.74–1.70]. In order to test the
hypothesis that µmaleN1, we compared the fit of Model 1
to the fit of a model where µmale is constrained to the null
value of 1 (Table 2,Model 2). This comparison yielded χ2
(1df )=3.21, p=0.036 (one-sided), leading us to reject the
null hypothesis of µmale=1 in favor of the alternative
hypothesis that there is a positive male incompatibility
effect. The model that constrains the female effect to one
but allows for a male effect [µmale=1.44, 90% CI: 1.05–
1.98] (Table 2, Model 3) had the smallest AIC of the
models we examined (AIC=1681.2), providing further
support that Rhesus D incompatibility is a risk factor for
schizophrenia only in males. Table 3 provides the countsTable 2
Evaluation of four different models of risk due to Rhesus D
incompatibility
Model μmale
a (90% CI) μfemale
b (90% CI) Log
likelihood
AIC c
1 1.44 (1.05, 1.98) 1.12 (0.74, 1.70) −834.51 1683.0
2 =1 1.14 (0.76, 1.71) −836.12 1684.2
3 1.44 (1.05, 1.98) =1 −834.62 1681.2
4 1.30 (1.01, 1.67) =μmale −834.82 1681.6
a μmale= the relative risk for male incompatible offspring.
b μfemale= the relative risk for female incompatible offspring.
c AIC=Akaike's Information Criterion (smaller is better).of parental genotype combinations underlying Model 3
for the 277 families in order to get a better feel for the data.
The counts are fractional because mother–child and
father–child dyads are probabilistically apportioned in an
unbiased manner conditional on the possible mating
types. Under the assumption of mating symmetry in the
population and the null that incompatibility does not
matter to risk, there should be about equal numbers of
Rhesus D negative mothers and Rhesus D positive fathers
as families with Rhesus D positive mothers and Rhesus D
negative fathers. By contrast, Table 3 demonstrates an
asymmetry in those counts and this finding is consistent
with the alternative hypothesis that Rhesus D incompat-
ibility is a risk factor for schizophrenia in males. Table 3
also reveals an even greater asymmetry between the dd-
mother/DD-father families versus the DD-mother/dd-
father families, which is consistent with every fetus
conceived by the former type of couple being subject to
incompatibility, whereas no fetus conceived by the latter
type would be incompatible.
In order to test the hypothesis that µfemaleN1, we
compared the fit of Model 1 to the fit of a model where
µfemale is constrained to the null value of 1 (Table 2,
Model 3). This comparison yielded χ2 (1df)=0.220,
p=0.319 (one-sided), consistent with the hypothesis that
there is no female incompatibility effect. To test the sex
independent model originally proposed (Palmer et al.,
2002), we then directly tested the hypothesis that the
incompatibility effects are independent of the sex of the
offspring by comparing the fit of Model 1 to a model
that assumes that the male and female incompatibility
effects are equal [µmale=µfemale, Table 2, Model 4]. This
comparison did not lead to a rejection of the null
hypothesis (χ2 (1df)=0.620, p=0.431 [two-sided]) and
thus fails to provide additional support for the hypoth-
esis that the incompatibility effect is exclusively for
male offspring.
3.2. Meta-analysis
We then performed a meta-analysis of three studies to
estimate sex-specific Rhesus D incompatibility risks for
Fig. 1. Individual study and pooled sex-specific estimates of Rhesus D
incompatibility relative risk for schizophrenia. Filled symbols denote
estimates for incompatible males; open symbols denote estimates for
incompatible females. Diamond=estimate derived from meta-analy-
sis; Triangle=estimate derived from data published in Hollister et al.
(1996); Square=estimate derived from data published in Insel et al.
(2005); Circle=estimate derived from current candidate gene study.
Solid vertical line denotes null value and dashed vertical line denotes
meta-analysis estimate for incompatible males.
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across the three studies (Q statistic for male offspring
data=2.07, p=0.356; Q statistic for female offspring
data=0.485, p=0.785) indicating that pooling their
results is justified (Fleiss, 1993). The pooled estimate of
µmale=1.64 with 90% CI 1.25–2.17 and the pooled
estimate of µfemale=1.07, with 90% CI 0.72–1.58. The
90% CI for µmale does not cover the null value of one,
supporting an incompatibility effect in male offspring;
while the 90% CI for µfemale includes the null value,
providing additional support for an incompatibility
effect that is limited to male offspring. Fig. 1 displays
the study-specific estimates of µmale, µfemale, and their
upper and lower 90% CI values. In each individual study
µmaleNµfemale which is consistent with the results of the
meta-analysis.
4. Discussion
We examined Rhesus D incompatibility as a sex-
dependent risk factor for schizophrenia using a
candidate gene approach in a large sample and by
performing a meta-analysis of the sex-specific incom-
patibility effects produced by datasets from three
studies. The candidate gene approach yielded several
lines of evidence to support a male incompatibility
effect. First, we rejected the null hypothesis of no male
incompatibility effect when comparing a model that
estimated the sex-specific incompatibility effects to a
model that constrained the male incompatibility effectto its null value; whereas we failed to reject the null
hypothesis of no female incompatibility effect with an
analogous model comparison. Second, we demon-
strated that a model that constrains the female effect
to one but allows for a male effect had the best fit by
AIC of the models we examined, further supporting that
Rhesus D incompatibility is a risk factor for schizo-
phrenia only in males. In our sample, the relative risk of
schizophrenia in male Rhesus D incompatible pregnan-
cies was greater than for female incompatible pregnan-
cies (1.44 and 1.12, respectively). However, when we
compared a model with these estimates of the male and
female incompatibility effects to a model that con-
strained the sex-specific effects to be equal, we found
that the two models were not statistically different, thus
failing to provide additional support for the hypothesis
that the incompatibility effect is exclusively for male
offspring.
By combining three datasets in the meta-analysis, we
increased the sample size for affected males to 358 and
affected females to 226 (a 12–18% increase from the
Finnish sample). The results of ourmeta-analysis yielded
the strongest evidence thus far that the incompatibility
effect is limited to male offspring. The point estimate of
the pooled female incompatibility effect is not only
smaller than that for males [µfemale=1.07, 90% CI 0.72–
1.58; µmale=1.64, 90% CI 1.25–2.17], it also does not
fall within the 90% CI for the male incompatibility
effect, and it is contained within a 90% CI that includes
the null value. Furthermore, the 90% CI for the male
incompatibility effect does not cover the null value of
one and the effect estimate for males does not fall within
the 90% CI for the female effect.
The results of our candidate gene analysis and
meta-analysis suggest that the effect of Rhesus D
incompatibility on the development of schizophrenia is
limited to male offspring. However, because the
sample size for females was ∼35% less than that of
the males, our study may have lacked sufficient
statistical power to detect a small female effect. On
the other hand, the estimated pooled relative risk for
females in the meta-analysis is 1.07, which is very
small in magnitude, leaving in question its substantive
meaning even if found to be statistically significant in
a larger sample. A null or very small female effect
relative to males is an important finding that allows for
hypothesis generation and testing to determine why
schizophrenia effects of Rhesus D incompatibility are
so much greater for male offspring compared to female
offspring.
One hypothesis is that male fetuses are at greater risk
because clinical manifestations of Rhesus D incompatibility
143C.G.S. Palmer et al. / Schizophrenia Research 104 (2008) 135–145are much more likely to occur in pregnancies with male
fetuses than with female fetuses. Although there is some
literature that suggests that Rhesus D negative mothers
are more likely to be immunized by male fetuses than
female fetuses (Renkonen and Timonen, 1967; Woo-
drow and Donohoe, 1968), there is no evidence that its
related condition of Rhesus D incompatibility HDN is
more likely to occur in subsequent pregnancies with
male fetuses than with female fetuses. Hence, this is
unlikely to explain male–female differences in the in-
compatibility effect.
A related hypothesis is that clinical manifestations of
Rhesus D incompatibility must surpass a threshold of
severity before they increase risk for schizophrenia, and
male fetuses are more likely to experience sequelae that
surpass this threshold than female fetuses. This hypothesis
predicts that the clinical manifestations of Rhesus D
incompatibility would be more severe in pregnancies with
male fetuses than with female fetuses. Evidence to support
this hypothesis comes from Ulm et al. (1999), where they
found that compared to incompatible female fetuses,
incompatible male fetuses had a significantly lower relative
hemoglobin and hematocrit at their initial intravenous
transfusion, required more intravenous transfusions, and
were more likely to develop hydrops. In addition, more
male fetuses than female fetuses died in utero or during the
neonatal period (Ulm et al., 1999). An implication of this
hypothesis is that specific schizophrenia-effects of Rhesus
D incompatibility (i.e., hypoxia, hyperbilirubinemia) can
affect female fetuses but that females are less likely to
surpass the threshold compared to male fetuses.
A third hypothesis is that the timing of manifestations
of Rhesus D incompatibility during gestation coincides
with sex-specific maturational events such that the
developing male brain is more vulnerable to effects of
Rhesus D incompatibility than the developing female
brain. Research supports differences in brain maturational
rates in males and females (Cahill, 2006), where the pace
of cerebral development is slower in males than females
(Castle and Murray, 1991). Hence, the slower-maturing
brains of males may be vulnerable to environmental
insults for a longer period of time than the more quickly
maturing brains of females (Castle and Murray, 1991).
Placental transfer of maternal anti-D antibodies has been
observed as early as the 18th week of gestation (Adinolfi,
1985) and evidence of hemolytic disease in the fetus has
been demonstrated in the second trimester (Mollison,
1993), providing a timeframe for considering the effects
of Rhesus D incompatibility. Of note, male fetuses have
been found to require intravenous transfusion at an earlier
gestational age than female fetuses (male median
gestation age 24.5 weeks, range 18–35 weeks; femalemedian gestational age 31.0 weeks, range 22–36 weeks)
(Ulm et al., 1999), suggesting the possibility of a sex-
dependent vulnerability to the timing of Rhesus D
incompatible effects, with male fetuses experiencing an
earlier and longer window of vulnerability during
neurodevelopment than female fetuses. An implication
of this hypothesis is that males and females may be
equally vulnerable to the specific effects produced by
Rhesus D incompatibility, but that these effects must
occur at sex-dependent times during development. If this
is the case, it would mean that female fetuses may be at
increased risk for schizophrenia when subject to obstetric
complications that produce the same downstream effects
as HDN, e.g., hypoxia, hyperbilirubinemia, but that these
effects must occur earlier in gestation to increase risk for
schizophrenia in females.
A fourth hypothesis is that male fetuses are at greater
risk because male developing brains are more vulnerable
to one or both specific effects of the clinical manifesta-
tions of Rhesus D incompatibility, i.e., hypoxia, hyperbi-
lirubinemia, than female developing brains. Data bearing
on this hypothesis are conflicting with some studies
finding higher rates of hypoxic-related obstetric compli-
cations in males with schizophrenia (Hultman et al.,
1999), and others finding higher rates in females
with schizophrenia than in males with schizophrenia
(Goldstein et al., 2000).
Our findings suggest that the effects of Rhesus D
incompatibility, and hence, adverse prenatal environ-
ments, on the development of schizophrenia may
depend on offspring sex. To further bolster this
conclusion, one would expect to observe an increased
risk among 2nd or later born incompatible males, but not
for females. However, because our datasets were not
conducive for jointly analyzing the effect of prior
Rhesus D incompatibility exposure and offspring sex in
either the candidate gene or meta-analysis approach
(due to the relatively small sample sizes of incompatible
affected offspring and other study design limitations),
we are unable to provide this additional piece of
evidence. Nevertheless, our sex-dependent finding is
particularly interesting in light of recent work demon-
strating that HLA-B matching as a schizophrenia risk
factor is limited to females (Palmer et al., 2006). Not
only do these findings suggest that sex differences
during fetal neurodevelopment should be investigated to
fully elucidate the etiology of schizophrenia, but they
allow investigators to generate several testable hypoth-
eses regarding the effects of the prenatal environment on
schizophrenia risk which may lead to further under-
standing of the basic processes underlying schizophre-
nia and preventative strategies as well.
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